These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8530802)

  • 1. Mycobacteria--related to the aetiopathogenesis of primary biliary cirrhosis?
    Berg PA; Klein R
    J Hepatol; 1995 Jul; 23(1):103. PubMed ID: 8530802
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological markers of primary biliary cirrhosis: diagnosis, prognosis and subsets.
    Bassendine MF; Yeaman SJ
    Hepatology; 1992 Mar; 15(3):545-8. PubMed ID: 1544636
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary biliary cirrhosis: nature of autoantigens.
    Bassendine MF; Yeaman SJ
    Springer Semin Immunopathol; 1990; 12(1):73-83. PubMed ID: 1695030
    [No Abstract]   [Full Text] [Related]  

  • 4. Sjögren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases.
    Fujikura S; Davis PA; Prindiville T; Leung P; Fox RI; Gershwin ME
    J Rheumatol; 1990 Nov; 17(11):1453-7. PubMed ID: 1703233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes.
    Fussey SP; Lindsay JG; Fuller C; Perham RN; Dale S; James OF; Bassendine MF; Yeaman SJ
    Hepatology; 1991 Mar; 13(3):467-74. PubMed ID: 1999318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the alpha-keto acid dehydrogenase complexes and their involvement in primary biliary cirrhosis.
    Yeaman SJ; Bassendine MF; Fittes D; Hodgson DR; Heseltine L; Brown HJ; Mutimer DJ; James OF; Fussey SP
    Ann N Y Acad Sci; 1989; 573():183-91. PubMed ID: 2634346
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis.
    Bassendine MF; Jones DE; Yeaman SJ
    Semin Liver Dis; 1997 Feb; 17(1):49-60. PubMed ID: 9089910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The association between autoantibodies to enzyme and diseases--with special reference to antibodies to pyruvate dehydrogenase complex (PDH)].
    Moteki S; Amaki S; Nakano E
    Rinsho Byori; 1998 Apr; 46(4):317-23. PubMed ID: 9594621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression.
    Heseltine L; Turner IB; Fussey SP; Kelly PJ; James OF; Yeaman SJ; Bassendine MF
    Gastroenterology; 1990 Dec; 99(6):1786-92. PubMed ID: 2227292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
    Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
    Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
    Van de Water J; Ansari AA; Surh CD; Coppel R; Roche T; Bonkovsky H; Kaplan M; Gershwin ME
    J Immunol; 1991 Jan; 146(1):89-94. PubMed ID: 1984455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies of sera from patients with primary biliary cirrhosis recognize the alpha subunit of the decarboxylase component of human branched-chain 2-oxo acid dehydrogenase complex.
    Mori T; Ono K; Hakozaki M; Kasukawa R; Kochi H
    J Hepatol; 2001 Jun; 34(6):799-804. PubMed ID: 11451161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of mitochondrial autoreactivity in primary biliary cirrhosis.
    Mackay IR; Gershwin ME
    Immunol Today; 1989 Sep; 10(9):315-8. PubMed ID: 2480138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary biliary cirrhosis clinical research single-topic conference.
    Lindor KD; Hoofnagle J; Maddrey WC; Mackay IE; Dickson ER
    Hepatology; 1996 Mar; 23(3):639-44. PubMed ID: 8617447
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to atypical mycobacteria in primary biliary cirrhosis.
    O'Donohue J; McFarlane B; Bomford A; Yates M; Williams R
    J Hepatol; 1994 Nov; 21(5):887-9. PubMed ID: 7890908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis.
    Van de Water J; Cooper A; Surh CD; Coppel R; Danner D; Ansari A; Dickson R; Gershwin ME
    N Engl J Med; 1989 May; 320(21):1377-80. PubMed ID: 2716784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
    Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
    Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis.
    Leung PS; Iwayama T; Prindiville T; Chuang DT; Ansari AA; Wynn RM; Dickson R; Coppel R; Gershwin ME
    Hepatology; 1992 Mar; 15(3):367-72. PubMed ID: 1371979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody against dihydrolipoamide dehydrogenase, the E3 subunit of the 2-oxoacid dehydrogenase complexes: significance for primary biliary cirrhosis.
    Maeda T; Loveland BE; Rowley MJ; Mackay IR
    Hepatology; 1991 Dec; 14(6):994-9. PubMed ID: 1959888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-mitochondrial autoantibodies of primary biliary cirrhosis as a novel probe in the study of the biosynthetic regulation of the yeast 2-oxo acid dehydrogenase complexes.
    Sudoyo H; Marzuki S
    Biochem Biophys Res Commun; 1989 Jan; 158(1):220-7. PubMed ID: 2643431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.